This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree
29.09.1980
502 3056
mario.plaas@ut.ee

Career

Institutions and positions
01.03.2021–...   
University of Tartu, Assistant professor of Translational Medicine (0,50)
01.01.2014–...   
University of Tartu, Head of the Laboratory Animal Centre (0,50)
2008–28.02.2014   
Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences, Researcher (0,50)
20.06.2005–31.12.2013   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, transgeense tehnoloogia laborijuhataja (1,00)
01.01.2004–31.12.2005   
OÜ Naxo, Specialist of transgenic tehnology
01.01.2003–31.12.2005   
OÜ Visgenyx, microinjectionist
 
 
Education
2005–2013   
Univesity of Tartu, Phd, developmental biology
2003–2005   
Univesity of Tartu, MSc degree, developmental biology
1999–2003   
Univesity of Tartu, BSc degree, genetehnology
1996–1999   
Haapsalu gymnasium

Qualifications

 
 
Honours & awards
2021, Mario Plaas, National research prizes for the best research papers completed and published during the previous four years
2011, Mario Plaas, The U.S. Embassy, the Baltic American Freedom Foundation (BAFF), and the American Chamber of Commerce in Estonia (AmCham) selected KPA Scientific OÜ to the six finalists for the 2011 Estonian American Innovation Award.
2011, Mario Plaas, 3 place in Estonian business plan contest called “Brain storm”. Hepatitis Virus C infectable small animal models
2006, Mario Plaas, Nets prize for the bisnes plan of running the transgenic tehnology laboratory
2006, Mario Plaas, Nets ettevõtlus programmi raames pälvisin eripreemia transgeense tehnoloogia labori äriplaani eest
 
 
Fields of research
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.3. Genetics
ETIS CLASSIFICATION: 3. Health; 3.1. Biomedicine
 
 

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2021
1.1.
2020
1.1.
2019
1.1.
2019
1.1.
2019
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2014
1.1.
2013
1.2.
2013
5.1.
2013
1.1.
2012
1.1.
2011
1.1.
2011
1.1.
2010
1.1.
2010
1.1.
2009
1.1.
2009
1.1.
2009
5.1.
2009
1.1.
2008
1.1.
2008
1.1.
2007
1.3.
2007
1.1.
2006
5.2.
2004
1.1.
2003

Industrial property

30.08.2021
29.09.1980
502 3056
mario.plaas@ut.ee

Teenistuskäik

Töökohad ja ametid
01.03.2021–...   
Tartu Ülikool, Siirdemeditsiini kaasprofessor (0,50)
01.01.2014–...   
Tartu Ülikool, Bio- ja Siirdemeditsiini Instituudi Katseloomakeskuse juhataja (0,50)
2008–28.02.2014   
Eesti Maaülikool, Veterinaarmeditsiini ja loomakasvatuse instituut, Teadur (0,50)
20.06.2005–31.12.2013   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, transgeense tehnoloogia laborijuhataja (1,00)
01.01.2004–31.12.2005   
OÜ Naxo, transgeneetika spetsialist
01.01.2003–31.12.2005   
OÜ Visgenyx, mikroinjekteerija
 
 
Haridustee
2005–2013   
Tartu Ülikool , Arengubioloogia doktoriõpe
2003–2005   
2005 Tartu Ülikool MSc Arengubioloogias
1999–2003   
Tartu Ülikool Bakalaureuse kraad geenitehnoloogias
1996–1999   
Haapsalu Gümnaasium, keskharidus

Kvalifikatsioon

 
 
Teaduspreemiad ja tunnustused
2021, Mario Plaas, Eesti riigi teaduspreemia nelja viimase aasta teaduspublikatsioonide eest
2011, Mario Plaas, U.S. Saatkond, Baltic American Freedom Foundation (BAFF) ja American Chamber of Commerce in Estonia (AmCham) valisid osaühingu KPA Scientific 6 ettevõtte hulka, kes teevad aktiivselt innovatsiooni Ameerika Ühendriikidega
2011, Mario Plaas, 3 koht Eesti suurimal äriplaani konkursil "Ajujaht" . "Geneetiliselt humaniseeritud loommudelid Hepatiidi viirus C ravimiarenduseks".
2006, Mario Plaas, Nets prize for the bisnes plan of running the transgenic tehnology laboratory
2006, Mario Plaas, Nets ettevõtlus programmi raames pälvisin eripreemia transgeense tehnoloogia labori äriplaani eest
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.3. Geneetika
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.1. Biomeditsiin

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2021
1.1.
2020
1.1.
2019
1.1.
2019
1.1.
2019
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2014
1.1.
2013
1.2.
2013
5.1.
2013
1.1.
2012
1.1.
2011
1.1.
2011
1.1.
2010
1.1.
2010
1.1.
2009
1.1.
2009
1.1.
2009
5.1.
2009
1.1.
2008
1.1.
2008
1.1.
2007
1.3.
2007
1.1.
2006
5.2.
2004
1.1.
2003

Tööstusomand

30.08.2021

Search project

  • {{item.Name}}
Institution is projects' financier   Institution is projects' executor  
  • {{searchListItem.Name}}
All   Projects   Master projects   Subprojects  
New Frascati (2015)
Old and new Frascati
All
Ongoing
Finished
Beginning
Fuzzy
Precise
  • Found 26 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
PRGPRG878Exploration of the therapeutic potential of the active vitamin D analogues: focus on the mood disorders and obesity01.01.202031.12.2024Aleksandr ŽarkovskiUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine514 250,00 EUR
MUU8-2/T12158VLBSDevelopment of efficient animal reproduction technologies for the sustainable cattle breeding01.10.201231.08.2015Ülle JaakmaEstonian University of Life Sciences; Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences175 108,00 EUR
ETFETF7295The development of endocrine disorders in an animal model of Wolfram syndrome - Wfs1-deficient mouse.01.01.200831.12.2011Vallo TillmannUniversity of Tartu, Faculty of Medicine75 534,76 EUR
ETFETF5995Role of Gata-3 and related factors in the development of heart01.01.200431.12.2007Raivo RaidUniversity of Tartu, Faculty of Biology and Geography30 581,80 EUR
PSGPSG471GLP1 receptor agonist Liraglutide and NRF2 activator RTA-408 therapy to relieve neurodegenerative symptoms in rat model of Wolfram syndrome01.01.202031.12.2023Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine209 000,00 EUR
MUUSLOTI11182T (3.2.0701.11-0016)Anti-HCV drug development and screening technologies01.01.201231.12.2013Andres MeritsUniversity of Tartu; University of Tartu, Faculty of Science and Technology (old)872 230,20 EUR
MUU8-2/T8001VLVLEarly embryogenomics and epigenetic mechanisms of early development in mammals01.01.200830.03.2012Sulev KõksEstonian University of Life Sciences; Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences284 797,21 EUR
1.1.5.2.8-2/T9039VLVLDevelopment of cloning technology for the production of biopharmaceuticals from the transgenic cattle01.04.200928.02.2014Sulev KõksEstonian University of Life Sciences; Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences985 609,59 EUR
1.1.5.2.8-2/T7136VLVLStudies on animal cloning technologies01.09.200728.02.2008Sulev KõksEstonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences12 251,00 EUR
SFSF0180043s07Chronic dermatoses: pathogenetic mechanisms01.01.200731.12.2012Helgi SilmUniversity of Tartu, Faculty of Medicine330 564,92 EUR
MUUVMVBS16359Tender of laboratory animals to Latvian Biomedical Research and Study Centre01.09.201631.08.2018Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine38 000,00 EUR
MUULMVBSKATSE (OSI 2016/26 AK)Tender of laboratory animals to Latvian Institute of Organic synthesis01.12.201631.12.2019Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine130 000,00 EUR
MUULARBSKATSESupply of Laboratory Animals to the Latvian Institute of Organic Synthesis within the Framework of Implementation of ERDF Projects 2DP/2.1.1.1/13/APIA/VIAA/001 and 2DP/2.1.1.1/13/APIA/VIAA/00320.01.201520.07.2015Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine18 848,00 EUR
1.2.5.VMVBS19195Lifelong treatment with GLP 1 receptor agonist in rat model of Wolfram syndrome01.03.201928.02.2022Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine194 396,25 EUR
MUU8-2/T9052VLVLStudies on skin cell culture technologies01.04.200930.09.2009Rutt TabaEstonian University of Life Sciences; Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences16 745,24 EUR
ETFETF6232The function of Ric-8 gene in the mouse nervous system01.01.200531.12.2007Alar KarisUniversity of Tartu, Faculty of Biology and Geography40 001,18 EUR
MUULMVBSKATSE (BMC 2020/485)Procurement of Laboratory Animals14.12.202014.12.2022Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine40 000,00 EUR
MUULLOTI09092Producing of transgenic mice models01.06.200931.01.2011Mario PlaasUniversity of Tartu60 588,24 EUR
SFSF0182691s05Cellular, develomental and evolutionary factors in the development of organisms and in formation of animal biodiversity01.01.200531.12.2010Alar KarisUniversity of Tartu, Faculty of Biology and Geography; University of Tartu, Faculty of Science and Technology (old), Institute of Molecular and Cell Biology, University of Tartu; University of Tartu, Faculty of Science and Technology (old)785 824,90 EUR
TTTMVBS14064T National Centre for Translational and Clinical Research01.01.202031.03.2021Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine85 600,00 EUR
IUTIUT20-64National Centre for Translational and Clinical Research 01.01.201431.12.2019Mario PlaasUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine480 000,00 EUR
MUUSARFS11193T (3.2.0701.11-0009)Trangenic rat based disease models and imaging platforms01.12.201131.08.2015Allen KaasikUniversity of Tartu; University of Tartu, Faculty of Medicine621 321,00 EUR
MUULLOTITromboosi farmakogeneetilise test (Innovatsiooniosak)01.06.200915.07.2009Mario PlaasUniversity of Tartu3 163,63 EUR
MUUILOTI09149K (EU31760)Uute hepatiidiviirus C haigusmudelite väljatöötamine - HCV ravimite ning ravimeetodite prekliinilisteks testimisteks (eeluuring)01.10.200931.03.2010Mario PlaasUniversity of Tartu19 147,80 EUR
ETFETF9309Association of genetic variations in the Wfs1 gene and endoplasmic reticulum stress response with valproate-induced insulin resistance and obesitiy in human01.01.201231.12.2015Sulev HaldreUniversity of Tartu, Faculty of Medicine96 000,00 EUR